Filing Details
- Accession Number:
- 0001415889-24-016064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-07 18:20:19
- Reporting Period:
- 2024-06-05
- Accepted Time:
- 2024-06-07 18:20:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1759425 | Mirum Pharmaceuticals Inc. | MIRM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1547959 | Saira Ramasastry | C/O Mirum Pharmaceuticals, Inc. 989 E Hillsdale Blvd., Suite 300 Foster City CA 94404 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-05 | 5,000 | $14.12 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-05 | 5,000 | $25.68 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-06-05 | 5,000 | $0.00 | 5,000 | $14.12 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2024-06-05 | 8,779 | $0.00 | 8,779 | $26.30 |
| Common Stock | Restricted Stock Units | Acquisiton | 2024-06-05 | 5,703 | $0.00 | 5,703 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,500 | 2022-05-31 | 2031-08-15 | No | 4 | M | Direct |
| 8,779 | 2034-06-04 | No | 4 | A | Direct | |
| 5,703 | No | 4 | A | Direct |
Footnotes
- The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2025 annual stockholder meeting.
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting.
Billionaire Hedge Funds
